Clinical characteristics and outcome of Acinetobacter infections in CAPD patients

Perit Dial Int. 1994;14(2):174-7.
No abstract available

MeSH terms

  • Acinetobacter / drug effects
  • Acinetobacter Infections / drug therapy
  • Acinetobacter Infections / epidemiology*
  • Aminoglycosides
  • Anti-Bacterial Agents / therapeutic use
  • Cephalosporins / therapeutic use
  • Community-Acquired Infections / epidemiology
  • Community-Acquired Infections / microbiology
  • Cross Infection / epidemiology
  • Cross Infection / microbiology
  • Humans
  • Microbial Sensitivity Tests
  • Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
  • Peritonitis / drug therapy
  • Peritonitis / epidemiology
  • Peritonitis / microbiology*
  • Treatment Outcome

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Cephalosporins